中文名稱:兔抗B4GALNT2多克隆抗體
Background: |
B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]). |
Applications: |
ELISA, IHC |
Name of antibody: |
B4GALNT2 |
Immunogen: |
Fusion protein of human B4GALNT2 |
Full name: |
beta-1,4-N-acetyl-galactosaminyltransferase 2 |
Synonyms: |
B4GALT; GALGT2 |
SwissProt: |
Q8NHY0 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human liver cancer |
IHC Recommend dilution: |
30-150 |